-
-
-
-
-
-
-
Leerink Partners Downgrades Regeneron Pharma (REGN) to Market Perform, 'on LAG-3 Failure and Eylea Erosion Risk'
-
-
-
-
-
-
-
Tango Therapeutics Inc. (TNGX) PT Raised to $28 at Leerink Partners
-
-
-
-
-
-
-
Leerink Partners Reiterates Market Perform Rating on Boundless Bio Inc. (BOLD) following Q4 report, pipeline update
-
-
-
-
-
-
-
Cullinan Oncology Inc. (CGEM) PT Raised to $28 at Leerink Partners
-
-
-
-
-
-
-
Cogent (COGT) PT Raised to $50 at Leerink Partners
-
-
-
-
-
-
-
Ideaya Biosciences (IDYA) PT Raised to $30 at Leerink Partners
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Neutral Rating on Zymeworks (ZYME)
-
170 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

